Fetal growth and gestational age improve outcome predictions in neonatal heart surgery.


Journal

The Journal of thoracic and cardiovascular surgery
ISSN: 1097-685X
Titre abrégé: J Thorac Cardiovasc Surg
Pays: United States
ID NLM: 0376343

Informations de publication

Date de publication:
12 2022
Historique:
received: 10 12 2021
revised: 29 04 2022
accepted: 05 05 2022
pubmed: 25 6 2022
medline: 18 11 2022
entrez: 24 6 2022
Statut: ppublish

Résumé

Current risk adjustment models for congenital heart surgery do not fully incorporate multiple factors unique to neonates such as granular gestational age (GA) and birth weight (BW) z score data. This study sought to develop a Neonatal Risk Adjustment Model for congenital heart surgery to address these deficiencies. Cohort study of neonates undergoing cardiothoracic surgery during the neonatal period captured in the Pediatric Cardiac Critical Care Consortium database between 2014 and 2020. Candidate predictors were included in the model if they were associated with mortality in the univariate analyses. GA and BW z score were both added as multicategory variables. Mortality probabilities were predicted for different GA and BW z scores while keeping all other variables at their mean value. The C statistic for the mortality model was 0.8097 (95% confidence interval, 0.7942-0.8255) with excellent calibration. Mortality prediction for a neonate at 40 weeks GA and a BW z score 0 to 1 was 3.5% versus 9.8% for the same neonate at 37 weeks GA and a BW z score -2 to -1. For preterm infants the mortality prediction at 34 to 36 weeks with a BW z score 0 to 1 was 10.6%, whereas it was 36.1% for the same infant at <32 weeks with a BW z score of -2 to -1. This Neonatal Risk Adjustment Model incorporates more granular data on GA and adds the novel risk factor BW z score. These 2 factors refine mortality predictions compared with traditional risk models. It may be used to compare outcomes across centers for the neonatal population.

Identifiants

pubmed: 35750509
pii: S0022-5223(22)00612-2
doi: 10.1016/j.jtcvs.2022.05.022
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2003-2012.e1

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Martina A Steurer (MA)

Department of Pediatrics, University of California San Francisco, San Francisco, Calif. Electronic address: martina.steurer@ucsf.edu.

Kurt Schuhmacher (K)

Mott Children's Hospital, Michigan Medicine, Ann Arbor, Mich.

Jill J Savla (JJ)

Children's Hospital of Philadelphia, Philadelphia, Pa.

Mousumi Banerjee (M)

School of Public Health, University of Michigan, Ann Arbor, Mich.

Nikhil K Chanani (NK)

Emory University, Atlanta, Ga.

Aaron Eckhauser (A)

University of Utah, Salt Lake City, Utah.

Justin Elhoff (J)

Baylor College of Medicine, Houston, Tex.

Jeffrey P Jacobs (JP)

University of Florida, Gainesville, Fla.

Katherine Mikesell (K)

Mott Children's Hospital, Michigan Medicine, Ann Arbor, Mich.

Shabnam Peyvandi (S)

Department of Pediatrics, University of California San Francisco, San Francisco, Calif.

Jennifer Romano (J)

Mott Children's Hospital, Michigan Medicine, Ann Arbor, Mich.

Wenying Zhang (W)

Mott Children's Hospital, Michigan Medicine, Ann Arbor, Mich.

J William Gaynor (JW)

Children's Hospital of Philadelphia, Philadelphia, Pa.

Sarah Tabbutt (S)

Department of Pediatrics, University of California San Francisco, San Francisco, Calif.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH